<DOC>
	<DOCNO>NCT01028183</DOCNO>
	<brief_summary>The purpose research address comparative effectiveness harm therapeutic frequently give pregnant woman young infant include antibiotic , tocolytic agent , non-steroidal anti-inflammatory drug , H2 blocker , steroid . Our overall hypothesis use exist electronic medical record additional resource precise data collection 18 month follow successfully address current knowledge gap therapeutic effectiveness relative therapeutic harm . We use exist electronic medical record detail healthcare information enter 100,000 newborn year . These infant comprise `` Source Cohort '' . Nested within database , prospectively enroll 10 % population ( 10,000 newborn ) Follow-Up Cohort . The current electronic medical record Source Cohort capture therapeutic dosing sufficient precision conduct comparative effectiveness research sufficient change medical practice . The propose research : 1 ) ensure accurate data collection electronic monitoring real-time quality assurance evaluation Source Cohort ; 2 ) conduct 18 month post-hospital follow-up neurologic outcome disability Follow-Up Cohort . We complete assessment neurologic outcome disability use interactive web-based system , mail , telephone follow , in-person examination .</brief_summary>
	<brief_title>Impact Maternal-infant Therapeutics Safety , Mortality , Disability</brief_title>
	<detailed_description />
	<mesh_term>Lung Diseases</mesh_term>
	<mesh_term>Gastroesophageal Reflux</mesh_term>
	<mesh_term>Ductus Arteriosus , Patent</mesh_term>
	<mesh_term>Coal Tar</mesh_term>
	<criteria>Admitted Pediatrix Medical Group NICU &lt; =5 day life likely followup 18 month adjust age failure consent</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>5 Days</maximum_age>
	<verification_date>January 2013</verification_date>
	<keyword>therapeutic</keyword>
	<keyword>safety</keyword>
	<keyword>maternal</keyword>
	<keyword>neonatal</keyword>
</DOC>